User couchart47

Member for: 2 years (since Jan 25, 2023)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/INCB18424.html
About: ANETT: Period II demo regarding NEoadjuvant TAK-228 plus Ruxolitinib throughout patients together with endocrine receptor-positive cancers of the breast

Activity by couchart47

Score: 100 points (ranked #10)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for couchart47

Please log in or register to post on this wall.
...